The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liposomes Drug Delivery Market Research Report 2025
Synopsis
The global market for Liposomes Drug Delivery was valued at US$ 4030 million in the year 2024 and is projected to reach a revised size of US$ 7782 million by 2031, growing at a CAGR of 10.0% during the forecast period.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposomes Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Drug Delivery.
The Liposomes Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomes Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomes Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposomes Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposomes Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Liposomes Drug Delivery was valued at US$ 4030 million in the year 2024 and is projected to reach a revised size of US$ 7782 million by 2031, growing at a CAGR of 10.0% during the forecast period.
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposomes Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposomes Drug Delivery.
The Liposomes Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vials) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposomes Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposomes Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Spectrum Pharmaceuticals
Shanghai New Asia
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposomes Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposomes Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Liposomes Drug Delivery Market Overview
1.1 Product Definition
1.2 Liposomes Drug Delivery by Type
1.2.1 Global Liposomes Drug Delivery Market Value Comparison by Type (2024 VS 2031)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposomes Drug Delivery by Application
1.3.1 Global Liposomes Drug Delivery Market Value by Application (2024 VS 2031)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Global Liposomes Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Liposomes Drug Delivery Revenue 2020-2031
1.4.2 Global Liposomes Drug Delivery Sales 2020-2031
1.4.3 Global Liposomes Drug Delivery Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Liposomes Drug Delivery Market Competition by Manufacturers
2.1 Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2020-2025)
2.2 Global Liposomes Drug Delivery Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Liposomes Drug Delivery Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Liposomes Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Liposomes Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Liposomes Drug Delivery, Product Type & Application
2.7 Global Key Manufacturers of Liposomes Drug Delivery, Date of Enter into This Industry
2.8 Global Liposomes Drug Delivery Market Competitive Situation and Trends
2.8.1 Global Liposomes Drug Delivery Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Liposomes Drug Delivery Players Market Share by Revenue
2.8.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Liposomes Drug Delivery Market Scenario by Region
3.1 Global Liposomes Drug Delivery Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Liposomes Drug Delivery Sales by Region: 2020-2031
3.2.1 Global Liposomes Drug Delivery Sales by Region: 2020-2025
3.2.2 Global Liposomes Drug Delivery Sales by Region: 2026-2031
3.3 Global Liposomes Drug Delivery Revenue by Region: 2020-2031
3.3.1 Global Liposomes Drug Delivery Revenue by Region: 2020-2025
3.3.2 Global Liposomes Drug Delivery Revenue by Region: 2026-2031
3.4 North America Liposomes Drug Delivery Market Facts & Figures by Country
3.4.1 North America Liposomes Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Liposomes Drug Delivery Sales by Country (2020-2031)
3.4.3 North America Liposomes Drug Delivery Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Liposomes Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Liposomes Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Liposomes Drug Delivery Sales by Country (2020-2031)
3.5.3 Europe Liposomes Drug Delivery Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Liposomes Drug Delivery Market Facts & Figures by Region
3.6.1 Asia Pacific Liposomes Drug Delivery Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Liposomes Drug Delivery Sales by Region (2020-2031)
3.6.3 Asia Pacific Liposomes Drug Delivery Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Liposomes Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Liposomes Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Liposomes Drug Delivery Sales by Country (2020-2031)
3.7.3 Latin America Liposomes Drug Delivery Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Liposomes Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Liposomes Drug Delivery Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Liposomes Drug Delivery Sales by Country (2020-2031)
3.8.3 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Liposomes Drug Delivery Sales by Type (2020-2031)
4.1.1 Global Liposomes Drug Delivery Sales by Type (2020-2025)
4.1.2 Global Liposomes Drug Delivery Sales by Type (2026-2031)
4.1.3 Global Liposomes Drug Delivery Sales Market Share by Type (2020-2031)
4.2 Global Liposomes Drug Delivery Revenue by Type (2020-2031)
4.2.1 Global Liposomes Drug Delivery Revenue by Type (2020-2025)
4.2.2 Global Liposomes Drug Delivery Revenue by Type (2026-2031)
4.2.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2020-2031)
4.3 Global Liposomes Drug Delivery Price by Type (2020-2031)
5 Segment by Application
5.1 Global Liposomes Drug Delivery Sales by Application (2020-2031)
5.1.1 Global Liposomes Drug Delivery Sales by Application (2020-2025)
5.1.2 Global Liposomes Drug Delivery Sales by Application (2026-2031)
5.1.3 Global Liposomes Drug Delivery Sales Market Share by Application (2020-2031)
5.2 Global Liposomes Drug Delivery Revenue by Application (2020-2031)
5.2.1 Global Liposomes Drug Delivery Revenue by Application (2020-2025)
5.2.2 Global Liposomes Drug Delivery Revenue by Application (2026-2031)
5.2.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2020-2031)
5.3 Global Liposomes Drug Delivery Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Liposomes Drug Delivery Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gilead Sciences Liposomes Drug Delivery Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Pacira
6.3.1 Pacira Company Information
6.3.2 Pacira Description and Business Overview
6.3.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pacira Liposomes Drug Delivery Product Portfolio
6.3.5 Pacira Recent Developments/Updates
6.4 Sun Pharmaceutical
6.4.1 Sun Pharmaceutical Company Information
6.4.2 Sun Pharmaceutical Description and Business Overview
6.4.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sun Pharmaceutical Liposomes Drug Delivery Product Portfolio
6.4.5 Sun Pharmaceutical Recent Developments/Updates
6.5 Luye Pharma
6.5.1 Luye Pharma Company Information
6.5.2 Luye Pharma Description and Business Overview
6.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Luye Pharma Liposomes Drug Delivery Product Portfolio
6.5.5 Luye Pharma Recent Developments/Updates
6.6 Sigma-Tau Group
6.6.1 Sigma-Tau Group Company Information
6.6.2 Sigma-Tau Group Description and Business Overview
6.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sigma-Tau Group Liposomes Drug Delivery Product Portfolio
6.6.5 Sigma-Tau Group Recent Developments/Updates
6.7 Fudan-Zhangjiang
6.7.1 Fudan-Zhangjiang Company Information
6.7.2 Fudan-Zhangjiang Description and Business Overview
6.7.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fudan-Zhangjiang Liposomes Drug Delivery Product Portfolio
6.7.5 Fudan-Zhangjiang Recent Developments/Updates
6.8 Teva Pharmaceutical
6.8.1 Teva Pharmaceutical Company Information
6.8.2 Teva Pharmaceutical Description and Business Overview
6.8.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teva Pharmaceutical Liposomes Drug Delivery Product Portfolio
6.8.5 Teva Pharmaceutical Recent Developments/Updates
6.9 CSPC
6.9.1 CSPC Company Information
6.9.2 CSPC Description and Business Overview
6.9.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CSPC Liposomes Drug Delivery Product Portfolio
6.9.5 CSPC Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Company Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Novartis Liposomes Drug Delivery Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Kingond Pharm
6.11.1 Kingond Pharm Company Information
6.11.2 Kingond Pharm Description and Business Overview
6.11.3 Kingond Pharm Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Kingond Pharm Liposomes Drug Delivery Product Portfolio
6.11.5 Kingond Pharm Recent Developments/Updates
6.12 Spectrum Pharmaceuticals
6.12.1 Spectrum Pharmaceuticals Company Information
6.12.2 Spectrum Pharmaceuticals Description and Business Overview
6.12.3 Spectrum Pharmaceuticals Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Spectrum Pharmaceuticals Liposomes Drug Delivery Product Portfolio
6.12.5 Spectrum Pharmaceuticals Recent Developments/Updates
6.13 Shanghai New Asia
6.13.1 Shanghai New Asia Company Information
6.13.2 Shanghai New Asia Description and Business Overview
6.13.3 Shanghai New Asia Liposomes Drug Delivery Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai New Asia Liposomes Drug Delivery Product Portfolio
6.13.5 Shanghai New Asia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Liposomes Drug Delivery Industry Chain Analysis
7.2 Liposomes Drug Delivery Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Liposomes Drug Delivery Production Mode & Process Analysis
7.4 Liposomes Drug Delivery Sales and Marketing
7.4.1 Liposomes Drug Delivery Sales Channels
7.4.2 Liposomes Drug Delivery Distributors
7.5 Liposomes Drug Delivery Customer Analysis
8 Liposomes Drug Delivery Market Dynamics
8.1 Liposomes Drug Delivery Industry Trends
8.2 Liposomes Drug Delivery Market Drivers
8.3 Liposomes Drug Delivery Market Challenges
8.4 Liposomes Drug Delivery Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Liposomes Drug Delivery Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Liposomes Drug Delivery Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Liposomes Drug Delivery Market Competitive Situation by Manufacturers in 2024
Table 4. Global Liposomes Drug Delivery Sales (K Vials) of Key Manufacturers (2020-2025)
Table 5. Global Liposomes Drug Delivery Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Liposomes Drug Delivery Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Liposomes Drug Delivery Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Liposomes Drug Delivery Average Price (USD/Vial) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Liposomes Drug Delivery, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Liposomes Drug Delivery, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Liposomes Drug Delivery, Product Type & Application
Table 12. Global Key Manufacturers of Liposomes Drug Delivery, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Liposomes Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Liposomes Drug Delivery Sales by Region (2020-2025) & (K Vials)
Table 18. Global Liposomes Drug Delivery Sales Market Share by Region (2020-2025)
Table 19. Global Liposomes Drug Delivery Sales by Region (2026-2031) & (K Vials)
Table 20. Global Liposomes Drug Delivery Sales Market Share by Region (2026-2031)
Table 21. Global Liposomes Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Liposomes Drug Delivery Revenue Market Share by Region (2020-2025)
Table 23. Global Liposomes Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Liposomes Drug Delivery Revenue Market Share by Region (2026-2031)
Table 25. North America Liposomes Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 27. North America Liposomes Drug Delivery Sales by Country (2026-2031) & (K Vials)
Table 28. North America Liposomes Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Liposomes Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Liposomes Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 32. Europe Liposomes Drug Delivery Sales by Country (2026-2031) & (K Vials)
Table 33. Europe Liposomes Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Liposomes Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Liposomes Drug Delivery Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Liposomes Drug Delivery Sales by Region (2020-2025) & (K Vials)
Table 37. Asia Pacific Liposomes Drug Delivery Sales by Region (2026-2031) & (K Vials)
Table 38. Asia Pacific Liposomes Drug Delivery Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Liposomes Drug Delivery Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Liposomes Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 42. Latin America Liposomes Drug Delivery Sales by Country (2026-2031) & (K Vials)
Table 43. Latin America Liposomes Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Liposomes Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Liposomes Drug Delivery Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Liposomes Drug Delivery Sales by Country (2020-2025) & (K Vials)
Table 47. Middle East and Africa Liposomes Drug Delivery Sales by Country (2026-2031) & (K Vials)
Table 48. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Liposomes Drug Delivery Sales (K Vials) by Type (2020-2025)
Table 51. Global Liposomes Drug Delivery Sales (K Vials) by Type (2026-2031)
Table 52. Global Liposomes Drug Delivery Sales Market Share by Type (2020-2025)
Table 53. Global Liposomes Drug Delivery Sales Market Share by Type (2026-2031)
Table 54. Global Liposomes Drug Delivery Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Liposomes Drug Delivery Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Liposomes Drug Delivery Revenue Market Share by Type (2020-2025)
Table 57. Global Liposomes Drug Delivery Revenue Market Share by Type (2026-2031)
Table 58. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2020-2025)
Table 59. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2026-2031)
Table 60. Global Liposomes Drug Delivery Sales (K Vials) by Application (2020-2025)
Table 61. Global Liposomes Drug Delivery Sales (K Vials) by Application (2026-2031)
Table 62. Global Liposomes Drug Delivery Sales Market Share by Application (2020-2025)
Table 63. Global Liposomes Drug Delivery Sales Market Share by Application (2026-2031)
Table 64. Global Liposomes Drug Delivery Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Liposomes Drug Delivery Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Liposomes Drug Delivery Revenue Market Share by Application (2020-2025)
Table 67. Global Liposomes Drug Delivery Revenue Market Share by Application (2026-2031)
Table 68. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2020-2025)
Table 69. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2026-2031)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Liposomes Drug Delivery Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Gilead Sciences Company Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 78. Gilead Sciences Liposomes Drug Delivery Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Pacira Company Information
Table 81. Pacira Description and Business Overview
Table 82. Pacira Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 83. Pacira Liposomes Drug Delivery Product
Table 84. Pacira Recent Developments/Updates
Table 85. Sun Pharmaceutical Company Information
Table 86. Sun Pharmaceutical Description and Business Overview
Table 87. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 88. Sun Pharmaceutical Liposomes Drug Delivery Product
Table 89. Sun Pharmaceutical Recent Developments/Updates
Table 90. Luye Pharma Company Information
Table 91. Luye Pharma Description and Business Overview
Table 92. Luye Pharma Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 93. Luye Pharma Liposomes Drug Delivery Product
Table 94. Luye Pharma Recent Developments/Updates
Table 95. Sigma-Tau Group Company Information
Table 96. Sigma-Tau Group Description and Business Overview
Table 97. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 98. Sigma-Tau Group Liposomes Drug Delivery Product
Table 99. Sigma-Tau Group Recent Developments/Updates
Table 100. Fudan-Zhangjiang Company Information
Table 101. Fudan-Zhangjiang Description and Business Overview
Table 102. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 103. Fudan-Zhangjiang Liposomes Drug Delivery Product
Table 104. Fudan-Zhangjiang Recent Developments/Updates
Table 105. Teva Pharmaceutical Company Information
Table 106. Teva Pharmaceutical Description and Business Overview
Table 107. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 108. Teva Pharmaceutical Liposomes Drug Delivery Product
Table 109. Teva Pharmaceutical Recent Developments/Updates
Table 110. CSPC Company Information
Table 111. CSPC Description and Business Overview
Table 112. CSPC Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 113. CSPC Liposomes Drug Delivery Product
Table 114. CSPC Recent Developments/Updates
Table 115. Novartis Company Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 118. Novartis Liposomes Drug Delivery Product
Table 119. Novartis Recent Developments/Updates
Table 120. Kingond Pharm Company Information
Table 121. Kingond Pharm Description and Business Overview
Table 122. Kingond Pharm Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 123. Kingond Pharm Liposomes Drug Delivery Product
Table 124. Kingond Pharm Recent Developments/Updates
Table 125. Spectrum Pharmaceuticals Company Information
Table 126. Spectrum Pharmaceuticals Description and Business Overview
Table 127. Spectrum Pharmaceuticals Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 128. Spectrum Pharmaceuticals Liposomes Drug Delivery Product
Table 129. Spectrum Pharmaceuticals Recent Developments/Updates
Table 130. Shanghai New Asia Company Information
Table 131. Shanghai New Asia Description and Business Overview
Table 132. Shanghai New Asia Liposomes Drug Delivery Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2020-2025)
Table 133. Shanghai New Asia Liposomes Drug Delivery Product
Table 134. Shanghai New Asia Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Liposomes Drug Delivery Distributors List
Table 138. Liposomes Drug Delivery Customers List
Table 139. Liposomes Drug Delivery Market Trends
Table 140. Liposomes Drug Delivery Market Drivers
Table 141. Liposomes Drug Delivery Market Challenges
Table 142. Liposomes Drug Delivery Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Liposomes Drug Delivery
Figure 2. Global Liposomes Drug Delivery Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Liposomes Drug Delivery Market Share by Type: 2024 & 2031
Figure 4. Liposomal Doxorubicin Product Picture
Figure 5. Liposomal Amphoteracin B Product Picture
Figure 6. Liposomal Paclitaxel Product Picture
Figure 7. Others Product Picture
Figure 8. Global Liposomes Drug Delivery Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Liposomes Drug Delivery Market Share by Application: 2024 & 2031
Figure 10. Fungal Infection Therapy
Figure 11. Cancer & Tumor Therapy
Figure 12. Others
Figure 13. Global Liposomes Drug Delivery Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Liposomes Drug Delivery Market Size (2020-2031) & (US$ Million)
Figure 15. Global Liposomes Drug Delivery Sales (2020-2031) & (K Vials)
Figure 16. Global Liposomes Drug Delivery Average Price (USD/Vial) & (2020-2031)
Figure 17. Liposomes Drug Delivery Report Years Considered
Figure 18. Liposomes Drug Delivery Sales Share by Manufacturers in 2024
Figure 19. Global Liposomes Drug Delivery Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Liposomes Drug Delivery Players: Market Share by Revenue in Liposomes Drug Delivery in 2024
Figure 21. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Liposomes Drug Delivery Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Liposomes Drug Delivery Sales Market Share by Country (2020-2031)
Figure 24. North America Liposomes Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Liposomes Drug Delivery Sales Market Share by Country (2020-2031)
Figure 28. Europe Liposomes Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 29. Germany Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Liposomes Drug Delivery Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Liposomes Drug Delivery Revenue Market Share by Region (2020-2031)
Figure 36. China Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Liposomes Drug Delivery Sales Market Share by Country (2020-2031)
Figure 46. Latin America Liposomes Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Liposomes Drug Delivery Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Liposomes Drug Delivery by Type (2020-2031)
Figure 56. Global Revenue Market Share of Liposomes Drug Delivery by Type (2020-2031)
Figure 57. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2020-2031)
Figure 58. Global Sales Market Share of Liposomes Drug Delivery by Application (2020-2031)
Figure 59. Global Revenue Market Share of Liposomes Drug Delivery by Application (2020-2031)
Figure 60. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2020-2031)
Figure 61. Liposomes Drug Delivery Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
